GREY:TSTIF - Post by User
Post by
Drrwongon Sep 27, 2017 11:31pm
241 Views
Post# 26751792
Sell-side Analysts Ratings/Price Targets
Sell-side Analysts Ratings/Price TargetsBasically all the sell-side analysts reiterated their buy ratings and price targets on TSO3 today, following the press release morning on FDA requesting additional information.
RBC: Doug Miehm--outperform, PT $4.25
Scotia: Alan Ridgeway--outperform, PT $4.5
Canaccord: Neil Maruoka--buy, PT $5.25
Laurentian: Nick Agostino--spec buy, PT $5
National Bank: Endri Leno--outperform, PT $5.5
Echelon: Doug Loe--buy, PT $5.5
If any of you have the acutual report themselves (besides the Canaccord one that we saw already), please post it on the blog...much appreciated.
Cheers